Perhaps this helps explain why there are no Japanese universities in the THES-QS top 20 in 2009? For example, the difficulties around foreign personnel who teach and conduct research continue. Also, the report cites an innovation--fixed term positions--as an improvement but if anything such contractual posts have helped contribute to instability in research and unfair treatment of foreign personnel, women and junior colleagues.
White Paper on Science and Technology 2008 （Provisional Translation）
Elimination of Institutional Bottleneck to Dissemination of S&T Outcome
To create S&T-based innovation, it is necessary to ensure that research results achieved at
universities and other research institutions be steadily disseminated to society. Active exchange of researchers, smooth implementation of research activities, industry-academia-government cooperation, etc. have great effects not only on activation of R&D but on the return of research results to society and are the keys for enhancing effects of human and material investment on S&T. In order to realize this, approaches for elimination of institutional bottleneck in various aspects, such as the research exchange system, fixed-term system for researchers, independent administrative institution system, national university corporation system, and the intellectual property system, were performed to obtain significant progress. However, it is often said that there still exist institutional bottlenecks: emigration and immigration management of foreign researchers; working environment of female researchers who are involved in childbirth and child rearing; treatment of retirement allowance associated with movement between the research institutions; and fund procurement environment of research institutions have been identified. Among those, it is very important that elimination of institutional bottlenecks relating to clinical research involving clinical trials is pointed out. In our country encountering an aging society with a declining birth rate, which is the fastest in the world, clinical research involving clinical trials is the R&D means for realizing innovation leading to health enhancement of our nation and activation of the research is considered to bring great national benefits. It is essential to ensure that Japanese nationals can have earlier access to the world’s most advanced medical technologies; that the Japanese medical industry can aggressively pursue R&D activities and sharpen its international competitive edge; and that the health of the nation will further improve by
eliminating institutional bottlenecks obstructing research activities and promoting clinical research
involving clinical trials.